Fred Alger Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Fred Alger Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8,000	Closed	-$388K	–	540
2019 Q3	$388K	Sell	8,000 -16,500	-67%	-$860K	﹤0.01%	379
2019 Q2	$1.29M	Buy	24,500 +2,500	+11%	+$144K	0.01%	321
2019 Q1	$1.16M	Sell	22,000 -1,000	-4%	-$49.1K	﹤0.01%	319
2018 Q4	$944K	Buy	23,000 +1,000	+5%	+$37.5K	﹤0.01%	322
2018 Q3	$836K	Sell	22,000 -9,788	-31%	-$434K	﹤0.01%	335
2018 Q2	$1.44M	Buy	31,788 +23,788	+297%	+$1.08M	0.01%	302
2018 Q1	$386K	Buy	+8,000	New	+$446K	﹤0.01%	381
2017 Q4	–	Sell	-3,000	Closed	-$93K	–	605
2017 Q3	$93K	Sell	3,000 -2,000	-40%	-$56.2K	﹤0.01%	392
2017 Q2	$137K	Sell	5,000 -11,000	-69%	-$327K	﹤0.01%	396
2017 Q1	$590K	Buy	16,000 +4,000	+33%	+$101K	﹤0.01%	354
2016 Q4	$173K	Sell	12,000 -7,000	-37%	-$123K	﹤0.01%	355
2016 Q3	$438K	Buy	19,000 +2,000	+12%	+$38.1K	﹤0.01%	361
2016 Q2	$282K	Buy	+17,000	New	+$343K	﹤0.01%	405
2016 Q1	–	Sell	-16,050	Closed	-$519K	–	615
2015 Q4	$519K	Sell	16,050 -1,800	-10%	-$77.9K	﹤0.01%	432
2015 Q3	$753K	Buy	+17,850	New	+$842K	﹤0.01%	403

Other funds holding GBT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fred Alger Management's GBT Position: Q4 2019 in Review

Fred Alger Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2019, closing a stake of 8,000 shares — an estimated $388K sold.

Fred Alger Management first reported a position in GBT in Q3 2015 and held it in 15 quarters. The position peaked at $1.44M in Q2 2018. 234 funds tracked by Wall St. Rank hold GBT as of Q4 2019.

Fred Alger Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
Fred Alger Management sold 8,000 Global Blood Therapeutics, Inc. shares in Q4 2019, an estimated $388K.
Fred Alger Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 15 quarters.
Fred Alger Management's Global Blood Therapeutics, Inc. position peaked at $1.44M in Q2 2018.
234 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2019.

Based on Fred Alger Management's 13F filing for Q4 2019, filed 14 Feb 2020.